Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:6462804.
doi: 10.1155/2016/6462804. Epub 2016 Apr 11.

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions

Fariba Jaffary  1 , Mohammad Ali Nilforoushzadeh  2 , Amirhossein Siadat  3 , Elaheh Haftbaradaran  4 , Nazli Ansari  4 , Elham Ahmadi  4
Affiliations

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions

Fariba Jaffary et al. Dermatol Res Pract. 2016.

Abstract

Background. Cutaneous leishmaniasis is an endemic disease in Iran. Pentavalent antimonial drugs have been the first line of therapy in cutaneous leishmaniasis for many years. However, the cure rate of these agents is still not favorable. This study was carried out to compare the efficacies of intralesional glucantime with topical trichloroacetic acid 50% (TCA 50%) + glucantime and fractional carbon dioxide laser + glucantime in the treatment of cutaneous leishmaniasis. Methods. A total of 90 patients were randomly divided into three groups of 30 to be treated with intralesional injection of glucantime, a combination of topical TCA 50% and glucantime, or a combination of fractional laser and glucantime. The overall clinical improvement and changes in sizes of lesions and scars were assessed and compared among three groups. Results. The mean duration of treatment was 6.1 ± 2.1 weeks in all patients (range: 2-12 weeks) and 6.8 ± 1.7, 5.2 ± 1.0, and 6.3 ± 3.0 weeks in glucantime, topical TCA plus glucantime, and fractional laser plus glucantime groups, respectively (P = 0.011). Complete improvement was observed in 10 (38.5%), 27 (90%), and 20 (87%) patients of glucantime, glucantime + TCA, and glucantime + laser groups, respectively (P < 0.001). Conclusion. Compared to glucantime alone, the combination of intralesional glucantime and TCA 50% or fractional CO2 laser had significantly higher and faster cure rate in patients with cutaneous leishmaniasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The mean and 95% CI of scar size in three groups.
See this image and copyright information in PMC

References

    1. Choi C. M., Lerner E. A. Leishmaniasis as an emerging infection. Journal of Investigative Dermatology Symposium Proceedings. 2001;6(3):175–182. doi: 10.1046/j.0022-202x.2001.00038.x. - DOI - PubMed
    1. Nilforoushzadeh M. A., Jaffary F., Moradi S., Derakhshan R., Haftbaradaran E. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis. BMC Complementary and Alternative Medicine. 2007;7, article 13 doi: 10.1186/1472-6882-7-13. - DOI - PMC - PubMed
    1. Kassi M., Afghan A. K., Rehman R., Kasi P. M., Kassi M. Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS Neglected Tropical Diseases. 2008;2(10, article e259) doi: 10.1371/journal.pntd.0000259. - DOI - PMC - PubMed
    1. Reithinger R., Dujardin J.-C., Louzir H., Pirmez C., Alexander B., Brooker S. Cutaneous leishmaniasis. The Lancet Infectious Diseases. 2007;7(9):581–596. doi: 10.1016/s1473-3099(07)70209-8. - DOI - PubMed
    1. Piscopo T. V., Mallia Azzopardi C. Leishmaniasis. Postgraduate Medical Journal. 2007;83(976):649–657. - PMC - PubMed